Sobi: Wills Hughes-Wilson appointed Vice President Government Affairs & Policy
Wills Hughes-Wilson has been appointed Vice President, Government Affairs & Policy with responsibility for Sobi's contacts with all stakeholders in the health policy area.
Wills comes from Genzyme Corporation, now part of the French Sanofi Group, where she was Vice President Health/Market Access Policy, Europe. She joined Genzyme in 2005. Prior to Genzyme she was Executive Director of Emerging Biopharmaceutical Enterprises (EBE), a specialized group of the European Federation of Pharmaceuticals Industries & Associations (EFPIA) representing the interest of biotechnology companies in Europe. She has also worked in the animal health/veterinary medicines industry and at Ernst & Young Consulting.
Will Hughes Wilson, born in 1971, is an Honors graduate in Law from University of Durham in the UK. She will report to CEO Geoffrey McDonough and will be a member of the Executive Leadership Team, based in Brussels. She will assume her position in February 2012.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.